The intricate process of developing targeted cancer therapies often relies on specialized chemical intermediates that form the backbone of life-saving drugs. Among these, 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride, with the CAS number 183322-17-0, stands out as a critical component in the synthesis of Erlotinib. This article explores the significance of this compound and its role in advancing oncological treatments.

2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride is characterized by its specific molecular structure, which makes it an ideal precursor for the synthesis of Erlotinib. Erlotinib's mechanism of action involves inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, thereby interrupting signaling pathways that drive cancer cell growth and proliferation. The demand for this intermediate is directly linked to the global need for effective cancer medications.

For pharmaceutical companies aiming to buy 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride, understanding its chemical properties is essential. Its typical appearance as a white crystalline solid and its solubility characteristics are important for handling and processing. As a reliable CAS 183322-17-0 manufacturer, we ensure that the product supplied is of the highest purity, often exceeding 97%, which is critical for pharmaceutical applications. Exploring the price of 183322-17-0 from reputable suppliers will aid in your procurement strategy.

As a seasoned pharmaceutical intermediate supplier, we understand the complexities involved in drug development. We are committed to providing researchers and manufacturers with the high-quality intermediates they need. Whether you are looking for a reliable manufacturer in China or seeking the best possible price for 183322-17-0, our company is equipped to meet your demands with professionalism and efficiency, supporting the development of next-generation cancer therapies.